Efeito de rolipram na maturação in vitro, expressão gênica e desenvolvimento embrionário em bovinos by Santana, Breno Barros de et al.
Arq. Bras. Med. Vet. Zootec., v.71, n.5, p.1433-1444, 2019 
Effect of Rolipram on in vitro maturation, gene expression and  
embryonic development in bovines 
 
[Efeito de rolipram na maturação in vitro, expressão gênica e desenvolvimento  





















1Programa de pós-graduação ˗ Universidade Federal Rural de Pernambuco ˗ Garanhuns, PE 
2Aluno de graduação ˗ Universidade Federal Rural de Pernambuco ˗ Garanhuns, PE 
3Universidade Federal Rural de Pernambuco ˗ UFRPE – Recife, PE 
4 Programa de pós-graduação ˗ Universidade de Fortaleza ˗ UNIFOR ˗ Fortaleza, CE 
5 Universidade de Fortaleza ˗ UNIFOR ˗ Fortaleza, CE 




The aim of this work was to evaluate the effect of the Rolipram during the maturation of bovine oocytes 
and gene expression of embryos produced in vitro. Bovine ovaries were collected in slaughterhouse. The 
COCs were selected and divided into 5 groups: Control 0 time; Control: IVM for 24 hours; Rolipram 
treatments with IVM blocking for 24 hours in maturation medium containing (100, 150 and 200µM). 
After 24 hours all groups were reseated in IVM for another 24 hours. Subsequently COCs were subjected 
to the same IVM system and fertilized, being checked for cleavage post fertilization and for blastocyst. In 
addition, performed expression of the following genes: Mater, BMP15 and Bax. No difference was found 
in gene expression. Of oocytes evaluated shortly after follicular aspiration, 79.00% were in GV, GVBD, 
MI, while 13.40%, were in MII and 7.60%, D/NI. Significant difference was observed in different 
concentrations (T100, T200 and T150µM) in oocytes that have reached the MII phase compared to 
control treatments (P= 0.003). Differences were observed in cleavage rate (P< 0.05) between T150 and 
T200 when compared to the C/24 Group. A high difference was observed on blastocyst rate (P< 0.001) 
among treatments compared to the control group. 
 




O objetivo deste trabalho foi avaliar o efeito do rolipram durante a maturação de oócitos bovinos, 
expressão gênica e embriões produzidos in vitro. Os ovários bovinos foram coletados no matadouro. Os 
COCs foram selecionados e divididos em cinco grupos: controle 0 tempo; controle: MIV por 24 horas; 
tratamentos rolipram com bloqueio MIV por 24 horas em meio de maturação contendo 100, 150 e 
200µM. Após 24 horas, todos os grupos foram recolocados em MIV por mais 24 horas. 
Subsequentemente COCs foram submetidos ao mesmo sistema MIV e fertilizados, sendo avaliada a taxa 
de clivagem e de blastocisto, além da expressão dos seguintes genes: Mater, BMP15 e Bax. Nenhuma 
diferença foi observada na expressão gênica. Dos oócitos avaliados logo após a aspiração folicular, 
79,0% estavam em GV, GVBD, MI, enquanto 13,40%  estavam em MII, e 7,60% em D/NI. A diferença 
significativa foi observada em diferentes concentrações (T100, T200 e T150µM) em oócitos que 
atingiram a fase MII em comparação aos tratamentos de controle (P=0,3). Diferenças foram observadas 
nas taxas de clivagem (P<0,5) entre T150 e T200 quando comparadas com as taxas do grupo C/24. Uma 
grande diferença foi observada na taxa de blastocisto (P<0,1) entre os tratamentos em relação ao grupo 
controle.  
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INTRODUCTION 
 
Assisted reproductive techniques (ART) are 
increasingly used in order to solve problems of 
infertility. The success of these techniques 
depends on the supply of viable oocytes in a 
stage suitable for its use (Moura et al., 2009). 
Despite advances, regarding the improvement of 
medium and time of exposure to these medium, 
in vitro production of bovine embryos (IVP) has 
remained stable, with nuclear maturation and 
fertilization rates around 80%, and blastocyst 
production between 35-40%, and on average, 
only 30% of these embryos are able to generate 
pregnancy after transfer (Pontes et al., 2011). 
 
When oocytes are matured in vivo, blastocyst 
rates improve compared to in vitro matured 
(IVM). These results demonstrate that IVM is 
still a limiting step to increase the efficiency of 
these techniques (Pontes et al., 2009). Oocytes 
used for IVM are deprived of changes that occur 
during the period of follicular dominance, 
because they spontaneously resume meiosis 
when removed from the follicular environment 
(Thomas et al., 2002). Therefore, it is likely that 
many of the oocytes recovered to be used in the 
ART have a reduced potential for development 
due to the fact that they are not competent or 
completely ready to be fertilized (Ponderato et 
al., 2001). An alternative could be to prevent this 
premature resumption of meiosis after removing 
from follicular environment inducing a meiotic 
block (Adona et al., 2008). 
 
The blockage of meiosis could possibly provide 
additional time for the oocyte to undergo 
biochemical and structural changes required to 
support fertilization and have proper embryonic 
development (Dieleman et al., 2002). Several 
substances have been used to block meiosis, such 
as Adenil Cyclase (AC) activators such as 
forskolin, maturation-promoting factor (MPF) 
inhibitors such as 6-dimetilaminopurina (6-
DMAP), roscovitine and butyrolactone-I and 
Phosphodiesterase (PDE) inhibitors such as 
cilostamida, milrinone, rolipram and the 1-3-
isobutyl, metilxantina (IBMX) (Kubelka et al., 
2000; Dode and Adona, 2001; Ponderato et al., 
2001; Adona and Leal, 2004). 
 
Among the inhibitors we can highlight the 
specifics of PDE-4, including Rolipram, whose 
effect is to prevent the degradation of AMPc in 
bovine oocytes, resulting in its accumulation in 
cumulus cells and oocyte, keeping gap junctions 
stable, retarding resumption of meiosis (Thomas 
et al., 2002; Gilchrist e Thompson, 2007). These 
modifications in the conditions of pre-maturing 
oocyte in a presence of an inhibitor of nuclear 
maturation has been used in order to achieve a 
better synchronization between nuclear and 
cytoplasmic maturation processes (Sirard et al., 
1992; Sirard and Coenen, 1993; Franz et al., 
2002; Le Beaux et al., 2003; Machatkova et al., 
2004).  
 
It is known that oocyte competence is closely 
related to a certain amount of specific transcripts 
present in mRNA, accumulated during the 
development of the oocyte and the final phase of 
the foliculogenesis (Sirard et al., 2006; Sánchez 
and Smitz, 2012). In this way, the differences 
between oocyte viability can also be related to a 
difference in gene expression patterns of certain 
transcripts (Caixeta et al., 2009). One of the 
genes encoding these transcripts include the 
MATER 1 (maternal antigen that embryos 
require), BMP15 (bone morphogenetic protein 
15), and Bax (protein X) (Hanrahan et al., 2004; 
Bebbere et al.,2008). Therefore, this work aimed 
to observe the effect of Rolipram on nuclear 
stage embryonic development and gene 
expression of transcribed Mater, BMP15, and 
BAX. 
 
MATERIALS AND METHODS 
 
Ethical clearance: Clearance was obtained from 
the Ethics Committee on Animal Use of the 
Universidade Federal Rural de Pernambuco 
CEUA-UFRPE. The study did not involve 
handling live animals. All reagents used in this 
study were purchased from Sigma-Aldrich (St. 
Louis, MO, USA) unless cited. The rolipram 
(R6520) was diluted in dimethyl sulfoxide 
(DMSO) to a concentration of 20mg/mL and 
stored at -20°C. Bovine oocytes were collected 
from a local abattoir 5 minutes from the 
laboratory and immediately transported in saline 
0.9% NaCl, supplemented with 50mg/L of 
gentamicin at a temperature of 37°C, where 1993 
cumulus oocytes complexes (COCs) from 
follicles between 2 and 8mm in diameter were 
aspirated using 10mL syringe attached to 25 x 8 
needles. 
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The COCs were selected from Grade I to Grade 
III (Blondin and Sirard, 1995). After selection, 
oocytes were washed in TCM-199 HEPES, 
which consisted of TCM-199 containing Hank's 
salts and L-glutamine (Gibco, Life Technologies, 
NEW YORK, USA) supplemented with 25mM 
HEPES, 0.2mM pyruvate and 0.4% bovine fetal 
serum. To evaluate the effect of Rolipram on the 
resumption of meiosis, COCs (n= 630) were 
divided into eight repetitions with average 16 
COCs per group, underwent IVM for 24 hours in 
the following treatments: T0-stripped, stained 
and evaluated after aspiration; T1 – IVM 
medium without inhibitor; T2-100µM rolipram; 
T3-150µM rolipram and T4-200µM rolipram.  
 
The COCs were transferred to drops of 100µL in 
a Petri dish (35x10mm Corning, 430165), 
covered with mineral oil and kept in incubator at 
38.5°C and 5% CO2. The IVM medium consisted 
of TCM-199 containing Earle's salts and L-
glutamine (Gibco, Life Technologies, NEW 
YORK, USA) supplemented with 0.2mM 
pyruvate, 2.2mg/mL sodium bicarbonate, 
5.0mg/mL LH (Bioniche, Belleville, ON, 
Canada), 0.5mg/mL FSH (Bioniche, Belleville, 
ON, Canada), 0.4% bovine Fetal Serum and 
50µg/mL gentamicin. After culture, to assess the 
progression of meiosis, oocytes were denuded 
and stained with Hoechst 33342 (10µg/mL) and 
analyzed under an epifluorescence microscope 
(Leica DM2500). Oocytes were classified 
according to the stage of nuclear maturation as 
germination vesicle (GV), germinal vesicle break 
down (GVBD), Metaphase I (MI and Metaphase 
II (MII). 
 
In order to assess whether the blockage induced 
meiosis was reversible, COCs from control and 
treatment groups (n= 431) divided into eight 
repetitions with an average of 13 COCs per 
group were submitted to IVM for 24 hours under 
the treatments described. After 24 hours of IVM, 
COCs were washed with maturation without 
inhibitor and transferred to drops of 100µL of 
maturation medium without inhibitor covered by 
mineral oil and cultured with 38.5°C and 5% 
CO2 for over 24 hours. After this period, meiotic 
progression assessment was carried out. 
 
Groups containing 25 COCs, on average, divided 
into eight repetitions (n= 815) after going 
through the blocking process and resumption of 
meiosis were fertilized in vitro. For IVF, frozen 
semen from the same Bull and same batch were 
used. Frozen semen was thawed at 37°C for 30 
seconds and prepared according to thePercoll 
gradient technique (Amersham Biosciences, 17-
0891-01). Sperm were added to micro drops of 
fertilization at a final concentration of 2 x 10
6 
sperm/mL. Fertilization was done in TALP-IVF.  
 
The sperm and oocytes were co-incubated in 
drops of 100µL of medium under mineral oil in a 
Petri dish (35 x 10mm. Corning, 430165) for a 
period of 18 hours. After 18 hours of IVF, 
oocytes were partially stripped with a micro-
pipette of 50µL. After partial denudation, 
oocytes were transferred to SOF (synthetic 
oviduct fluid) in drops of 100µL and 48 hours of 
in vitro culture (D3), and the cleavage rate was 
assesed. Cleaved oocytes remained in the culture 
medium and the rest were removed and 
discarded. On the fifth day (D5) of in vitro 
culture a partial change of medium (feeding - 
40%) was done and from the seventh (D7) and 
the eighth day (D8) the assessment of blastocyst 
formation rate (D7) was done. Culture was 
conducted in an incubator at a temperature of 
38.5°C, containing 5% CO2 in atmospheric air 
and 99% humidity. Every 48 hours, 50% of the 
medium was renewed. Cleavage rate was 
reviewed 48 hours post fertilization (Stringfellow 
and Seidel, 1998). 
 
Groups composed of 3 to 4 COCs, on average, 
divided into 4 repetitions (n= 117) were stripped 
mechanically after aspiration and in all 
treatments 24h after blockage and 48h after 
blockage release, were stored in -80°C until 
extraction. Extraction was performed using the 
buffer lysis of the SuperScript
®
 caps III 
CellsDirect
™
 cDNA Synthesis Kit (Thermo 
Scientific), adding to each sample 10µL of 
Resuspension Buffer and 1µL of Lysis Enhancer. 
Then, the samples were incubated at 75°C for 
10min and treated with DNAse I. Reverse 
transcription was performed using oligo (dT) 20 
starters and the SuperScript III enzyme (Thermo 
Scientific), according to manufacturer's 
recommendations, to 50°C for 1 hour. The 
cDNA of each experimental group remained 
stored in freezer at -20°C until further use. 
 
For the quantification of gene expression in the 
samples obtained, primers were designed for the 
genes Mater, BMP15, and Bax. The gene for β-
Actin was used as a reference gene. For each 
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primer used, standard curves were performed for 
determining efficiency of each gene 
amplification, which were established between 
90 and 110%. 
 
For all the qPCRs, the TaqMan
®
 Gene 
Expression Master Mix (Thermo Scientific) was 
used, 1.5µL of cDNA, 400nM of each primer 
and 400nM of TaqMan specific probe (Table 1) 
in a final volume of 20µL. The reactions were 
incubated at 50°C for 2 minutes and 95°C for 10 
minutes, followed by 50 cycles of 95°C for 15 
seconds and 60°C for 1 minute in a thermal 
cycler StepOne Plus (Applied Biosystems). 
Negative controls were prepared with the cDNA 
omitted during reaction. Reactions were made in 
duplicate for each sample (from all groups) of 
their respective repetition in optical 96 wells 
plates (Applied Biosystems, Foster City, CA, 
USA). Relative quantification was performed 
using the ΔΔCT method (Livak and Schmittgen, 
2001), normalizing the results by gene 
expression of β-Actin. 
 
All variables studied over the times and 
treatments have been subjected to ANOVA. The 
contrasts between the mean were made by Tukey 
test, with significant difference of α= 0.05. 
Sigma Stat 3.1. (SYSTAT Software, Inc., 
SYSTAT SigmaPlot, SigmaStat are registered 
trademarks of Systat Software, Inc. 2004) were 
used. 
 
Table 1. Starters and probes used for determination of gene expression patterns 
Gene Primer Forward* Primer Reverse* Probe* 




























The oocytes evaluated shortly after follicular 
aspiration (zero-time control-C/0), 32.00% 
(52/159) were in germinal Vesicle (GV), 2.60% 
(4/159) in the germinal vesicle breakdown 
(GVBD), 44.38% (70/159) in metaphase I (MI), 
13.40% (21/159) in metaphase II (MII), and 
7.60% (12/159) degenerates or not identified 
(D/NI). For the percentage of oocytes that 
reached M-II, a significant difference was 
observed between control compared to all 
treatments (P= 0,003; Table 2). In Experiment 1, 
no difference (P > 0.05) was seen among 
treatments with oocytes treated at concentrations 
of 100 (T100), 150 (T150) and 200 µM (T200) 
of Rolipram when compared with the stages of 
GV, GVGBD, MI. With respect to the 
percentage of oocytes that have reached the MII 
phase we observed a reduction as the inhibitor 
concentration was increasing, showing 
significant differences (P = 0.003) T100, T150 
and T200, compared to control. With the other 
treatments, T100 showed no difference (Table 2). 
 
In the second part of the experiment, bovine 
oocytes treated after 24 hours of blocking have 
undergone an extra 24h of IVM without the 
blocker and then evaluated according to the 
stages of nuclear development. No differences 
(P< 0.05) were observed in any of the stages 
evaluated (Table 3). 
 
  
Effect of Rolipram… 
Arq. Bras. Med. Vet. Zootec., v.71, n.5, p.1433-1444, 2019 1437 
Table 2. Percentage (%), mean (    ) and Standard Deviation (SD) of nuclear stage from bovine oocytes 
pre-matured during 24 hours with Rolipram 
Groups N oocytes (  ±SD) 
Nuclear Stage (% and   ±SD) 
GV GVBD MI MII D/NI 
C/24 



























































GV: germinal vesicle; GVBD: germinal vesicle breaks down; MI: metaphase I; MII: metaphase II; D/NI: 
Degenerated and/or not identified. Different lower case letters in same column indicate statistical difference by 
ANOVA (P< 0.05) among treatments and distinct phases. 
 
Table 3. Mean (  ) and Standard Deviation (SD) of nuclear stage of bovine oocytes pre-matured during 24 
hours with nuclear maturation inhibitor Rolipram, followed by 24 hours of in vitro culture 
Groups N oocytes/(   ±SD) 
Nuclear Stage (% and   ±SD) 
GV GVBD MI MII D/NI 
C/24 



























































GV: germinal vesicle; GVBD: germinal vesicle breaks down; MI: metaphase I; MII: metaphase II; D/NI: 
Degenerated and/or not identified. Different lower case letters in the same column indicate statistical difference by 
ANOVA (P< 0.05) among treatments and distinct phases. 
 
In a third experiment, groups of oocytes, after 
being exposed to the blocker, were fertilized in 
vitro by IVM process to evaluate cleavage rate in 
D3 and blastocyst rate in D8, and statistical 
differences were observed (P< 0.05) on the rate 
of cleavage between the T150 and T200 when 
compared to the Group C/24 and a statistical 
difference was seen in Blastocyst rate evaluated 
in D7 (P< 0.001) all treatments compared to 
control group (Table 4). 
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Table 4. Percentage Mean (  ) and Standard Deviation (SD) from embryonic development of bovine 
oocytes submitted to a pre-maturation of 24 hours with Rolipram plus 24 hours of in vitro culture without 
inhibitor 
Groups N oocytes (   ±SD) 
Embryonic Development (% -   ±SD)  
Cleaved D3 Blastocyst D7 
C/24 



































Different lower case letters at the same line indicate statistical difference by ANOVA (P< 0.05) between the same 
treatment; Different capital letters in the same column indicate statistical difference by ANOVA (P< 0.05) among 
treatments in distinct phases. 
 
No difference (P< 0.05) was observed with 
regard to gene expression studies, when 
compared control groups 0h and 24h with 
treatments 24h and 48 hours for different 




The low blastocyst rates obtained in the in vitro 
production technique can be justified by the use 
of immature oocytes, in general these have not 
yet acquired competence for development, due to 
their premature withdrawal from the follicular 
environment.  However, it is necessary to 
develop alternatives to improve IVM techniques, 
where this will offer appropriate conditions for 
the majority of oocytes to be capable of 
producing viable embryos. 
 
One of the first systems used to improve IVM 
efficiency was based on the proposed Protocol 
for (Albuz et al., 2010), where some changes 
were performed in an attempt to simulate the 
events occurring in in vivo maturation. This 
system is based on two stages, the first consists 
of a short period of time using AMPc modulator 
agents, causing a rapid increase of the intra 
oocyte levels, similar to the action of LH in vivo. 
Oocytes then undergo a period of prolonged 
IVM, in the presence of a PDE inhibitor, to keep 
oocytes at GV stage so they have an additional 
time to suffer modifications that occur before the 
actual maturation (Hyttel et al., 1997) and to 
acquire the competence for development 
(Kubelka et al., 2000; Mermillod et al., 2000). 
For this reason, this paper proposed the use of 
different concentrations of Rolipram, in order to 
induce meiotic block, reducing the risks of 
changes in the oocytes and possibly increasing 
embryonic development rates. 
 
In the first experiment evaluated increasing 
concentrations of Rolipram (100, 150 and 
200μM) were evaluated, and their effect on 
induction of meiotic block. The index of oocyte 
in GV found in the control group 0 hour in this 
study was similar to other studies (Marques et 
al., 2011) where they presented an average of 48. 
Different data were observed in a study done by 
other research groups (Dode and Adona, 2001) 
that reported 100% of GV rates at the time 0 
hour. 
 
The divergence of data found in the literature can 
be justified by the relationship between the time 
of slaughter of the animals and selection of 
oocytes as well as the use of follicles of 2 to 
8mm. These factors may contribute to the 
decrease in the resumption of meiosis of oocytes 
until time of evaluation. On this point, (Fry et al., 
1997) and (Machatkova et al., 2000) also noted 
that bovine oocytes recovered in ovaries of 
slaughterhouse are heterogeneous in terms of 
quality and competence, probably due to the 
diversity of age, breed, and reproductive status 
(follicle size, day of the estrus cycle, level of 
atresia and influence of dominant follicles) of 
cows that pass through the slaughterhouse in a 
given day which agree with our study because 
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slaughtered animals of our region are mostly 
older animals or withdrawn dairy cows. 
 
In the Group with oocytes blocked with 
Rolipram it was possible to observe that even 
increasing Rolipram concentration, there were no 
differences in effectiveness of meiotic retention. 
Similar results has been found (Thomas et al., 
2004), that did not observe differences using a 
concentration of 100μM in 9 hours of culture. 
Lopez et al. (2008) obtained a different result 
than noted above, when using concentrations of 
25, 50 and 75μM, and noted that the lowest and 
highest concentration showed lowest rates of 
maturation being these 31.25 and 28.61%, 
whereas the concentration of 50μM showed 
maturation of 76.83%. In our study data were 
different because the concentrations that 
obtained lower maturation rate were T150 and 
T200 where these presented 14.63 and 23.64% 
maturation rate. Thomas et al. (2004) using a 
system of 16 hours of pre-maturation at 
Rolipram concentrations of 50, 250 and 500μM 
observed a reduction in MII rates with increasing 
concentration. This factor was not observed in 
our study. 
 
The response to the block can be caused by 
several factors such as: the expression of 
different subtypes of PDE4 (A, B, C and D) or 
variants generated by alternative splicing, 
causing a wide variety of Phosphodiesterase 
isoforms with different catalytic activity 
regulation mechanisms (Aktas et al., 1995; 
Bevers et al., 1997). Similar results were 
described (Marques et al., 2011) where oocytes 
blocked with Burolactona I 150μM and 50μM 
Roscovitina showed higher percentage of 
oocytes in MI compared to GV. Demonstrating 
possible differences in the maturation kinetics 
depending on the blocker and its action 
mechanism. When hormones such as LH and 
FSH are added in the maturation medium they 
promote an improvement in COCs expansion 
(Younis and Brackett, 1992), stimulating 
production of signaling substances by somatic 
cells, inducing the resumption of meiosis. This is 
an important factor to be considered in the low 
result of oocytes in GV stage in time of pre-
maturation where the medium used in the pre-
maturation was similar to the IVM medium plus 
the blocker, so this medium has the addition of 
FSH which may have influenced the oocytes not 
to remain blocked in GV and continue maturing 
until the stage of MI. 
 
Adona et al. (2008) noted that most oocytes 
treated at concentrations of 100 (B100), 50 (B50) 
and 25μM (B25) of Burolactona I remained 
blocked on meiosis in the GV stage, on the 
proportions of 97.4, 84.4 and 65.1% respectively, 
with this you can see that the percentage of 
blockage decreases according to the 
concentration of the blocker. Similar effect was 
observed in our study showing 9.92, 17.07 and 
20.00% at concentrations of T100, T200 and 
T150 respectively. 
 
Regarding reversibility of meiotic blockage by 
Rolipram at the end of culture, no difference was 
seen between control group and treatments, 
however, differences were seen on GV 
percentage. Adona et al. (2008), when using the 
Burolactona I inhibitor in concentrations of 10 
and 100μM noted that even with a high rate of 
oocytes in MII a small portion of oocytes still 
remained in GV with 0.0 and 1.1 respectively, as 
the concentration of the blocker was increasing, 
the data in this study were varying, but increased 
when the concentration was T100 and T150 with 
data from 6.68 to 8.50% though at the 
concentration of T200 the amount of oocytes in 
GV declined to 3.60%. 
 
When we compare the oocytes in MII, these 
showed a variation of 58.09 to 60.37% 
depending on Rolipram concentration. Similar 
data were reported (Marques et al., 2011) with 
the Roscovitine with 75.31% of the oocytes and 
different with Burolactona I with 83.89% 
(Kubelka et al., 2000). Thus demonstrating that 
the pre-matured oocytes with Rolipram 
regardless of treatment, when compared to other 
nuclear maturation inhibitors the control group is 
able to reverse the meiotic block and resume 
meiosis reaching MII when removed from the 
medium containing inhibitors. In embryonic 
development, the present study found differences 
from cleavage until blastocyst rate. Higher 
cleavage rate was observed in T150 and T200 
being 39.00 and 36.05%. A study (Marques et 
al., 2011), using Burolactona I and Roscovitine 
found rates between 20 and 50% numerically 
similar to data found in this study (Adona et al., 
2008), also using Burolactona did not see 
differences in the cleavage rate being these  80-
86%. 
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Significant difference was observed in blastocyst 
rate evaluated in D7 between treatments and 
control group showing rates of C/24 33.99%, 
13.25% T100, T150 11.76% and T200 11.53% 
indicating that when we increase the 
concentration, the results decreased. Unlike the 
results of (Adona et al., 2008) and (Marques et 
al., 2011) in which pre-matured oocytes with 
Butyrolactone I for 24 hours showed similar 
results when compared to control group in the 
production of blastocysts. The likely causes of 
low efficiency in embryo production could be 
related to inhibitor concentrations. Lonergan et 
al. (2000) and Adona et al. (2008) showed that 
the meiotic block with high concentration of BL 
I (150μM) had adverse effects on embryonic 
development of bovine oocytes. 
 
Rizos et al. (2002) observed that the proportion 
of embryos produced by IVF is affected by the 
intrinsic quality of the oocyte, but that the quality 
of the embryos is affected by in vitro culture. In 
this sense when nuclear maturation of oocytes 
occurs over a long period of time, adding the 
culture and blockage time (> 42 hours) can affect 
the quality of embryos produced. Kim et al. 
(1997) suggested that oocytes that aged in vitro 
have decreased embryonic development, mainly 
by compromising cytoskeletal elements. Two 
facts should be taken into account in this result: a 
great time in culture disrupts nuclear and 
cytoplasmic structures resulting in errors of 
chromosome pairing and fall in the proportion of 
fertilization (Long et al., 1995; Hunter and 
Greve, 1997). 
 
These data suggest that the timing of the in vitro 
fertilization of oocytes with nuclear maturation 
inhibitors may affect quality of embryonic 
development. Lagutina et al. (2002) observed 
that 82.5% of the oocytes treated with 
Roscovitine reached maturation after 16 hours of 
IVM. The same observations were made  
(Hashimoto et al., 2002), using Butyrolactone I 
(more than 85% of the oocytes in MII with 18 
hours of IVM), as well as (Adona and Leal, 
2004) who have obtained more than 90% of the 
oocytes blocked with Butyrolactone I or 
Roscovitine in M II after 18 hours of IVM. This 
fact probably occurs due to the resumption of 
meiosis in these oocytes to be accelerated after 
the removal of the inhibitor, and indicates that 
these oocytes are already able to be fertilized 
with 16 or 18 hours of IVM. 
In the present study we could also analyze the 
relative abundance of genes potentially involved 
in oocyte competence, because consequences in 
meiotic inhibition on expression of some genes 
have not been discussed at length (Leal et al., 
2012). With respect to gene expression, MATER 
transcripts in mice appear to have an important 
role in activation of embryonic genome (WU et 
al., 1996; Tong et al., 2000). MATER transcripts 
are present in bovine oocytes from primary 
follicles (Pennetier et al., 2004) and its quantity 
is reduced with the resumption of meiosis, in 
both in vitro and in vivo maturation (Thélie et 
al., 2007). Which agree with the numerical drop 
in number of transcripts observed in our study 
when we compare the 0h group with treatment 
groups. 
 
However, variations in the amount of these 
transcripts may not be associated with oocyte 
competence to develop after in vitro fertilization 
(Mota et al., 2009). In a study conducted by (Wu 
et al., 1996;) and (Tong et al., 2000) with mice, 
it was possible to observe that although in the 
absence MATER adequate follicular 
development occurs, ovulation and fertilization 
with normal zygotes, embryos obtained do not 
develop beyond the 2-cell stage and tend to 
degenerate. Therefore, the block on the 
development observed in embryos cultured in 
vitro, which coincides with the EGA, are 
possibly related with the least amount of 
MATER reported in bovine oocytes matured in 
vitro (Pereira et al., 2010). This result is similar 
to our study, where concentrations of T150 T200 
showed the smallest quantities of transcripts and 
subsequently lower rates of cleavage and 
blastocyst formation. With respect to the profile 
of expression (Bebbere et al., 2008), in his 
studies with sheep, there was a decreased level of 
MATER along with oocyte maturation. Similar 
results have been found in mice (Wu et al., 1996) 
and pigs (Uzbekova et al., 2006). 
 
Aa study in sheep found that mRNA BMP15 
remained constant until the embryo reached the 8 
cell stage after which there was a significant 
reduction, apparently being more important in 
later stages of development (Bebbere et al., 
2008). It was possible to notice that as you 
increased concentration of Rolipram there was an 
increase in BMP15 gene expression 
demonstrating that this substance has influence 
on the expansion of cumulus cells, which reflects 
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directly on oocyte maturation. The lowest value 
of BMP15 has been the concentration of T100, 
which also presented highest rates of cleavage 
and blastocyst formation between treatments. 
 
The correlation of Bax overexpression with the 
acceleration of apoptosis is known, where 
evidence shows that oocytes with low Bax gene 
expression have a higher ability to stay viable 
with smaller probability of degeneration (Felici 
et al., 1999). Yang and Rajamahendran (2002) 
observed that the expression of BAX protein was 
higher in degenerated embryos and concluded 
that apoptosis is responsible for oocyte 
degeneration, fragmentation of the embryo and 
embryo loss. In our study we found that values of 
BAX among 24h treatment have increased 
according to the elevation of the blocker 
concentration, and correlate with the greater the 
concentration a higher meiotic block, suggesting 
that the oocytes are not yet competent or in 
acceleration of apoptosis and so less able to 
remain viable. On the other hand, after 
unblocking, there is a drop in the values of this 
gene expression showing no difference between 
treatments and values a bit higher than the C24, 
but still low cleavage rate and blastocyst 
formation suggesting that the block with 
Rolipram may predispose the acceleration of 
apoptosis, decreasing their ability to remain 
viable. 
 
Data on the influence of IVM on BAX gene 
expression in bovine embryos are still scarce. 
Warzych et al., (2007) published data on the 
expression of this gene in embryos resulting 
from oocytes matured in different culture 
conditions. However, we did not observe 
changes in relative abundance of transcripts of 
BAX in bovine oocytes and hatched blastocysts 
after in vitro maturation in medium 
supplemented with PVP-40, BSA or BFS 




It can be concluded that the use of Rolipram in a 
maturation system in concentrations of 100, 150 
and 200µM can provide a delay in nuclear 
maturation in MI without changing its 
reversibility irrespective of the concentration 
used and the concentration of 100µM can be 
used in a way that will not interfere significantly 
with embryonic development. 
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